INSTITUT CLAUDIUS REGAUD
🇫🇷France
Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers
Not Applicable
Not yet recruiting
- Conditions
- Urothelial CarcinomaRenal CancerProstate AdenocarcinomaAdenocarcinoma of EndometriumCutaneous MelanomaSoft Tissue Sarcoma (STS)Nonseminomatous Germ Cell TumorSeminomatous Germ Cell TumorUpper Aerodigestive Tract CarcinomaCervical Carcinoma
- First Posted Date
- 2025-05-13
- Last Posted Date
- 2025-05-23
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 450
- Registration Number
- NCT06967961
- Locations
- 🇫🇷
Oncopole Claudius Regaud, IUCT-O, Toulouse, France
Prostate Cancer Burden and Heterogeneity Evaluation Towards Liquid Biopsy: a Correlation Study to 18FDCFPyL PET and Patients Outcome
Not Applicable
Not yet recruiting
- Conditions
- Prostate Cancer
- First Posted Date
- 2025-04-08
- Last Posted Date
- 2025-04-08
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 80
- Registration Number
- NCT06917781
- Locations
- 🇫🇷
IUCT-O, Toulouse, France
Comparison of Different Methods of CAPTure of Circulating Tumour Cells (CTC) in Patients With Metastatic Breast or Prostate Cancer
Not Applicable
Not yet recruiting
- Conditions
- Metastatic Breast CancerMetastatic Prostate Cancer
- First Posted Date
- 2025-04-01
- Last Posted Date
- 2025-04-01
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 36
- Registration Number
- NCT06904625
- Locations
- 🇫🇷
IUCT-O, Toulouse, France
Evaluation of the Inflammation-based Index as a Predictive Marker of Clinical and Radiological Response in Patients Treated With Lu-177 Oxodotreotide for Intestinal Neuroendocrine Tumour
Not Applicable
Recruiting
- Conditions
- Intestinal Neuroendocrine Tumor
- First Posted Date
- 2025-03-14
- Last Posted Date
- 2025-04-10
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 150
- Registration Number
- NCT06876532
- Locations
- 🇫🇷
CHU de Bordeaux, Bordeaux, France
🇫🇷Centre François Baclesse, Caen, France
🇫🇷CHU de Lille, Lille, France
Proof of Concept to Assess the Feasibility of a Decentralised Pathway Coordinated by the Advanced Practice Nurse for Patients Receiving Oral Treatment for Cancer or Malignant Haemopathy (ACCELER PLATFORM)
Not Applicable
Recruiting
- Conditions
- Solid CancerHaematological Malignancies
- First Posted Date
- 2025-01-28
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 33
- Registration Number
- NCT06797037
- Locations
- 🇫🇷
Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France
Irradiation in Paediatrics: Neurocognition, Neuroimaging and Evaluation of Memory and Attention
Not Applicable
Not yet recruiting
- Conditions
- Brain Tumor, Pediatric
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 130
- Registration Number
- NCT06599879
- Locations
- 🇫🇷
CHU Angers, Angers, France
🇫🇷CHU de Bordeaux, Bordeaux, France
🇫🇷Centre François Baclesse, Caen, France
Reintegrating a Systematic Review Consultation With the General Practitioner After the Cancer Diagnosis Has Been Announced Into the Complex Cancer Patient Pathway: Feasibility Study
Not Applicable
Recruiting
- Conditions
- Solid Tumours
- Interventions
- Other: Patient care according to the DAMeGe protocol (organisation of a summary consultation with the GP)
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2025-01-22
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 171
- Registration Number
- NCT06589414
- Locations
- 🇫🇷
CH Auch, Auch, France
🇫🇷CHU Larrey, Toulouse, France
🇫🇷CHU Rangueil, Toulouse, France
Detection of Homologous Recombination Pathway Gene Mutations in Circulating Tumour DNA From BRCA-mutated Ovarian Cancer Patients Receiving First-line PARP Inhibitor Maintenance Therapy
Not Applicable
Recruiting
- Conditions
- Ovarian Cancer
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2025-05-01
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 130
- Registration Number
- NCT06588322
- Locations
- 🇫🇷
INSTITUT DE CANCEROLOGIE DE L'OUEST - Site Angers, Angers, France
🇫🇷Institut Bergonie, Bordeaux, France
🇫🇷Chu de Limoges, Limoges, France
Reduction in the Number of Chemotherapy Cycles in Combination With Pembrolizumab in First-line Treatment of PD-L1-positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinomas
Phase 2
Recruiting
- Conditions
- Squamous Cell Carcinoma of Head and Neck
- Interventions
- First Posted Date
- 2024-08-16
- Last Posted Date
- 2025-05-01
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 86
- Registration Number
- NCT06557889
- Locations
- 🇫🇷
CHU Poitiers, Poitiers, France
🇫🇷Chu Bordeaux - Hopital Saint André, Bordeaux, France
🇫🇷Chu Limoges, Limoges, France
Acceptability and Benefits of an Onco-sexology Program for Laryngectomy Patients and Their Partners
Recruiting
- Conditions
- ORL Cancer
- First Posted Date
- 2024-07-24
- Last Posted Date
- 2025-05-23
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 45
- Registration Number
- NCT06517355
- Locations
- 🇫🇷
IUCT-O, Toulouse, France